Medical Health & Life Science Research News

New report examines the Parkinson's disease treatment market to undertake strapping growth during 2018 to 2025

Medical Market Research

According to Stratistics MRC, the Global Parkinson'S Disease Treatment market is accounted for $4.08 billion in 2017 and is expected to reach $7.93 billion by 2026 growing at a CAGR of 7.7%.

Growing geriatric population coupled with neurological disorders, increasing investments in research & development activities, and raising healthcare awareness are some of the factors propelling the market growth during the forecast period.

However, availability of other treatments is hindering the market growth.

By therapeutic class, Carbidopa/Levodopa segment is prognosticated to witness strong growth rate over the forecast period due to its potentiality and large acceptance for the parkinson’s disease treatment.

Besides, online pharmacies are projected to grow at a higher growth rate during the forecast period.

Download a PDF Sample of this Report @ orbisresearch.com/contacts/request…486?utm_source=sd

By region, Asia Pacific is expected to witness highest growth rate due to growing medical tourism trend and raising medical infrastructure. Europe is dominating the global market with highest market revenue during the forecast period.

This dominance is driven by increasing geriatric population and raising expenses on healthcare.

Some of the key players in Parkinson’s disease Treatment market include GlaxoSmithKline Plc., Abbvie, Acadia, Boehringer Ingelheim, Daiichi Sankyo, Impax Laboratories, Inc., Lundbeck, Merck, Novartis, Salix Pharmaceuticals, Sun Pharma, Teva Pharmaceutical Industries Ltd., UCB, Valeant Pharmaceuticals, and Wockhardt Limited.

Enquiry report @ orbisresearch.com/contacts/enquiry…486?utm_source=sd

Therapeutic Class:
Monoamine oxidase B inhibitors (MAO-B inhibitors)
Dopamine precursors
Dopamine agonists (non-ergoline)
Catechol-O-methyl transferase (COMT) inhibitors
Carbidopa/Levodopa
Other Therapeutic Classes

Medical Devices:
Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
Deep Brain Stimulation (DBS) Devices

Patient Care Setting:
Hospitals 
Clinics

Distribution Channel:
Retail pharmacies
Online pharmacies
Hospital pharmacies
Drug stores

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players 
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Access the complete report with TOC & List of Tables @ orbisresearch.com/reports/index/pa…026?utm_source=sd

News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany about: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...
This email address is being protected from spambots. You need JavaScript enabled to view it.